2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1225146426 MD
Verify on CMS →

MARGARET ENGLAND, MD

Endocrinology, Diabetes & Metabolism Physician in SANTA MARIA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 345 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
42%
generic claims · 58% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
8.9352/100
▼ 74 pts below national avg 83.1 · [object Object]
Industry payments
$1.3K
77 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARGARET ENGLAND, MD reported a CMS MIPS final score of 8.9352/100 — below the 83.1 national average — and filed 2,527 Medicare Part D claims in 2023.

8.9352/100
MIPS score · -74 vs avg
3K
Part D claims, 2023
42%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARGARET ENGLAND, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

9 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARGARET ENGLAND, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARGARET ENGLAND, MD?

Below national average

NPI registry status

Active

Issued 08/28/2006

NPI 1225146426

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

2,527 4% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

8.9352/100 74.1648% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in California

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among California providers

California providers

Endocrinology, Diabetes & Metabolism Physician share within California

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within California

Medicare quality performance — MIPS

MARGARET ENGLAND, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
8.9352/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 8.9352/100 vs national avg 83.1

0%100%National avg83%8.9%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 8.9352/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARGARET ENGLAND, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 1300 E CYPRESS ST STE C2, SANTA MARIA, CA, 93454, with a listed phone of (805) 349-8972. NPI 1225146426 was issued on 08/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ENGLAND most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,527 prescription claims written by this provider, covering 345 Medicare beneficiaries and totaling roughly $2.1 million in drug spend, split 58% brand-name and 42% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 8.9352/100 for the 2023 performance year (Quality 0, Cost 29.784), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1300 E CYPRESS ST STE C2
SANTA MARIA, CA 93454

Provider Details

NPI 1225146426
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 08/28/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

8.9352
Final Score
Avg: 83.1
0
Quality
29.784
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARGARET ENGLAND, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.3K

Largest payer

Mannkind Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARGARET ENGLAND, MD. To verify MARGARET ENGLAND, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

MARGARET ENGLAND, MD — brand share 58.0%
Specialty average (est.)

58% brand-name claims vs 42% generic, on 2,527 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,527
Total Claims
$2.1M
Total Drug Cost
345
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,273
Total Day Supply
186,248
Brand vs Generic
58% brand / 42% generic
Brand Drug Cost
$2.0M
Generic Drug Cost
$40K

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
1.37
Gender Split
61% female / 39% male
Age Distribution
<65: 20, 65-74: 182, 75-84: 112, 85+: 31

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARGARET ENGLAND, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
458
Ozempic
Semaglutide
237
Trulicity
Dulaglutide
177
Metformin Hcl
173
Jardiance
Empagliflozin
135
Farxiga
Dapagliflozin Propanediol
133
Metformin Hcl Er
Metformin Hcl
62
Synthroid
Levothyroxine Sodium
57
Hydrochlorothiazide
39
Kerendia
Finerenone
37

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How MARGARET ENGLAND, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

MARGARET ENGLAND, MD's 2,527 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ENGLAND.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARGARET ENGLAND, MD's specialty?
MARGARET ENGLAND, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in SANTA MARIA, California. Credentials: MD.
How much does MARGARET ENGLAND, MD prescribe under Medicare Part D?
In 2023, MARGARET ENGLAND, MD wrote 2,527 Medicare Part D claims totaling $2.1M in drug costs for 345 beneficiaries.
What is MARGARET ENGLAND, MD's Medicare quality score?
MARGARET ENGLAND, MD has a CMS MIPS Final Score of 8.9352/100 (Quality: 0, Cost: 29.784). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARGARET ENGLAND, MD located?
MARGARET ENGLAND, MD is located at 1300 E CYPRESS ST STE C2, SANTA MARIA, CA, 93454. Phone: (805) 349-8972.
What is MARGARET ENGLAND, MD's NPI number?
MARGARET ENGLAND, MD's National Provider Identifier (NPI) is 1225146426, issued on 08/28/2006.
Does MARGARET ENGLAND, MD prescribe more brand-name or generic drugs?
MARGARET ENGLAND, MD's prescribing is 58% brand-name and 42% generic drugs by claim count, with $2.0M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does MARGARET ENGLAND, MD prescribe most often?
Based on 2023 Medicare Part D data, MARGARET ENGLAND, MD's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Trulicity. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARGARET ENGLAND, MD accept Medicare?
MARGARET ENGLAND, MD appears in CMS Medicare data with 2,527 Part D claims and 345 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARGARET ENGLAND, MD's credentials?
MARGARET ENGLAND, MD's NPI is 1225146426 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology